Document and Entity Information - shares |
6 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Feb. 08, 2020 |
|
| Document And Entity Information | ||
| Entity Registrant Name | Innovation Pharmaceuticals Inc. | |
| Entity Central Index Key | 0001355250 | |
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --06-30 | |
| Entity Small Business | true | |
| Entity Shell Company | false | |
| Entity Emerging Growth Company | false | |
| Entity Current Reporting Status | Yes | |
| Document Period End Date | Dec. 31, 2019 | |
| Entity Filer Category | Non-accelerated Filer | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2020 | |
| Entity Common Stock Shares Outstanding | 230,017,069 | |
| EntityFileNumber | 001-37357 | |
| EntityAddressAddressLine1 | 301 Edgewater Place | |
| EntityAddressAddressLine2 | Suite 100 | |
| EntityAddressPostalZipCode | 01880 | |
| EntityTaxIdentificationNumber | 300565645 | |
| EntityAddressCityOrTown | Wakefield | |
| LocalPhoneNumber | 921-4125 | |
| CityAreaCode | 978 | |
| EntityAddressStateOrProvince | MASSACHUSETTS |